NEW YORK (TheStreet) -- MetLife (MET) - Get Report stock is up by 2.41% to $40.37 in mid-morning trading on Friday, after the company confirmed it was considering a sale of MetLifePremierClientGroup.

The life insurance company is discussing a transaction regarding the U.S. adviser force with MassMutualFinancial Group, a mutual life insurance company based in Springfield, MA. 

"There can be no assurance that an agreement will be reached or that a transaction will be consummated," the company said in a statement on Thursday.

The company could sell about 4,000 sales people to MassMutual, the Wall Street Journal reports.

Separately, recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

TheStreet Ratings rates this stock as a "buy" with a ratings score of B-. The company's strengths can be seen in multiple areas, such as its attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had sub par growth in net income.

You can view the full analysis from the report here: MET

Image placeholder title

MET

data by

YCharts